Catalyst Wire Dossier Catalyst Wire Dossier

gB/MF59 CMV vaccine

glycoprotein B MF59-adjuvanted CMV vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for gB/MF59 CMV vaccine, covering 2017-07-06 to 2017-07-06. Get the full timeline:

Most recent: Clinical Trial Update: gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females [Phase 2]

See pricing